1 / 34

The TEXAS Wake Up and Breathe Quality Improvement Initiative: Data Collection Activities

The TEXAS Wake Up and Breathe Quality Improvement Initiative: Data Collection Activities. Terri Conner, PhD Nybeck Analytics Project Manager Texas Wake Up and Breathe Initiative. Overall Initiative Purpose. Improve care for ventilated patients Improve sedative weaning Speed extubation.

wilkinson-junior
Télécharger la présentation

The TEXAS Wake Up and Breathe Quality Improvement Initiative: Data Collection Activities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The TEXAS Wake Up and Breathe Quality Improvement Initiative: Data Collection Activities Terri Conner, PhD Nybeck Analytics Project Manager Texas Wake Up and Breathe Initiative

  2. Overall Initiative Purpose • Improve care for ventilated patients • Improve sedative weaning • Speed extubation

  3. Results of Observation Studies Audits from across the country show that • Spontaneous awakening trials (SATs) and Spontaneous breathing trials (SBTs) are only initiated 50% of the time • SBTs not coordinated with SATs

  4. Benefits of coupled SATs and SBTs time on ventilation up to 3 days time in hospital up to 4 days

  5. Texas Wake Up and Breathe Collaborative Structure • Designate champion • Baseline survey • Please complete this at your earliest convenience and return to Terri Conner at terri@nybeck.net • Monthly data submission and surveys • Monthly calls with our group

  6. Three tools • Monthly survey • Daily data collection tool • Monthly data submission

  7. Monthly SurveyAll Teach, All Learn • Aim • Tests conducted • Outcomes • Lessons learned • Barriers / breakthroughs • Plans for next month

  8. Data Collection Efforts • Track performance • Measure impact on outcomes • LOS • Mortality • Antibiotic usage • VAC, IVAC, VAP rates

  9. SAT/SBT Performance Documentation • Clinical champions should oversee SAT/SBT documentation • Integrate into existing processes • Daily care plans • Checklists • Develop your own process

  10. Daily Data Elements Excel spreadsheet tool • Automatic calculation • VAC • IVAC • Possible and probable VAP

  11. Outcome Definitions • VAC • Significant respiratory deterioration after >2 days of stability • IVAC • VAC • abnormal temp or WBC count • >4 days of new antibiotics

  12. Outcome Definitions • Possible VAP • IVAC • Either purulent sputum OR + sputum/BAL culture • Probable VAP • IVAC • Both purulent sputum AND + sputum/BAL culture

  13. Daily Data CollectionVAC Status

  14. Daily Data CollectionVAC Status

  15. Daily Data CollectionIVAC Status • Tmin, Tmax, WBCmin, WBCmax • Enter for a total of 5 days • Start 2 days prior to VAC onset

  16. Daily Data CollectionIVAC Status

  17. Daily Data CollectionIVAC Status

  18. Daily Data CollectionQAD Determination • QAD • New antibiotic prescribed or continued • Includes days between doses at extended intervals (> q 24 h) • Data are entered for up 10 days (4 days before VAC, on the VAC dx day, and 5 days after VAC)

  19. Antibiotic WorksheetQAD Determination

  20. Antibiotic WorksheetQAD Determination

  21. Daily Data CollectionIVAC Status

  22. Daily Data CollectionPossible/Probable VAP Status • Enter sputum/BAL gram stain and culture results • Polys • Epis • Culture • Growth > Threshold

  23. Daily Data CollectionPossible/Probable VAP Status

  24. Daily Data CollectionPossible/Probable VAP Status • POLYS • Sputum or BAL gram stain polymorphonucleated cells, neutrophils, or white blood cells • Enter 0 to 4 • 0: none • 1: few, rare, <10 cells/lpf • 2: moderate, >25 cells/lpf • 3: many • 4: abundant

  25. Daily Data CollectionPossible/Probable VAP Status • EPIS • Sputum or BAL gram stain epithelial cells or squamous cells • Enter 0 to 4 • 0: none • 1: few, rare, <10 cells/lpf • 2: moderate, >25 cells/lpf • 3: many • 4: abundant

  26. Daily Data CollectionPossible/Probable VAP Status

  27. Daily Data CollectionPossible/Probable VAP Status

  28. Daily Data CollectionPossible/Probable VAP Status • CULTURE • Enter the culture result • Growth > Threshold • Yes • > 105 CFU/mL for endotracheal aspirate • > 104 CFU/mL for BAL • > 103 CFU/mL for protected specimen brush • Semi-quantitative equivalents also acceptable

  29. Daily Data CollectionPossible/Probable VAP Status

  30. Daily Data CollectionPossible/Probable VAP Status

  31. Daily Data CollectionPossible/Probable VAP Status

  32. Monthly Data Report • Hospital LOS • ICU LOS • Hospital discharge status • Ventilator days • SAT days – ‘real time’ data collection • SBT days - ‘real time’ data collection • Self-extubated / re-intubated (optional) • Outcomes (VAC,IVAC, poss/prob VAP)

  33. Monthly Data Report

  34. Questions? Repeat webinar on July 16th, 9am CT Please feel free to contact Terri at terri@nybeck.net or Rachel at rhardegree@tha.org

More Related